Rodrigo Saguez

Mr. Rodrigo Saguez

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
FSFelipe Salech
Felipe Salech
CMCarlos Marquez
Carlos Marquez
LLLydia Lera
Lydia Lera
BABárbara Angel
Bárbara Angel
RSRodrigo Saguez
Rodrigo Saguez
CACecilia Albala
Cecilia Albala

1 April 2021 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
LMLydia de la Caridad Lera Marques
Lydia de la Caridad Lera Marques
BABárbara Angel
Bárbara Angel
CMCarlos Marquez
Carlos Marquez
RSRodrigo Saguez
Rodrigo Saguez
CACecilia Albala
Cecilia Albala
Purpose: Many studies have demonstrated that Sarcopenia causes a serious impact on health, including death in older adults. The objective of this study was to determine the association of sarcopenia and pre-sarcopenia with all-cause mortality in older Chileans. Subjects and Methods: Follow-up of 2311 community-dwelling people ≥ 60y from the Alexandros cohort. Anthropometric measurements, handgrip strength, mobility, and physical performance tests were performed. Sarcopenia, pre-sarcopenia, and severe sarcopenia were defined using the 2010 European Working Group on Sarcopenia in Older People (EWGSOP1) algorithm. Muscle mass was estimated using a prediction model with cut-off points validated for the Chilean population. Physical performance was determined by 3 m walking speed or five chair-stands or time up go test (TUG). Mortality data were obtained from death certificates of the National Civil Registry. Life tables for survival data, Kaplan Meier estimations, and Cox regression were calculated. Results: The prevalence of sarcopenia was 20.2% (95% CI:18.6% to 21.9%) and similar in both sexes; pre-sarcopenia was identified in 20.4% (95% CI:18.8% to 22.1%) of the sample. Kaplan Meier survival estimates demonstrated lower survival rates for the people with sarcopenia and pre-sarcopenia (Log rank test for equality of survivor functions: p< 0.0001). A dose-response was observed in the survival rates according to the stages of sarcopenia, showing the lowest survival rates for the people with severe sarcopenia, followed by older adults with sarcopenia, pre-sarcopenia, and without sarcopenia (Log rank test for equality of survivor functions: p< 0.0001). After adjusting for age, sex, nutritional status, and number of chronic diseases, hazard ratios for death showed higher risk for subjects with sarcopenia (HR=1.47, 95% CI:1.17– 1.83) and pre-sarcopenia (HR=1.35, 95% CI:1.03– 1.78) in comparison with people without sarcopenia. Conclusion: The results confirm a dose–response increase in the risk of all-cause death in older adults with sarcopenia and pre-sarcopenia compared to non-sarcopenic individuals.

13 April 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
LMLydia de la Caridad Lera Marques
Lydia de la Caridad Lera Marques
BABárbara Angel
Bárbara Angel
CMCarlos Marquez
Carlos Marquez
RSRodrigo Saguez
Rodrigo Saguez
CACecilia Albala
Cecilia Albala
Background: The usual diagnosis of sarcopenia requires a dual-energy x-ray absorptiometry (DXA) exam, which has low accessibility in primary care for Latin American countries. Objective: The aim of this study is to design and validate software for mobile devices (Android, IOS) and computers, based on an adapted version of the diagnostic algorithm of sarcopenia proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). Methods: Follow-up exams were conducted on 430 community-dwelling Chileans 60 years and older (mean 68.2 years, SD 4.9) participating in the IsaMayor and Alexandros cohorts designed to study sarcopenia and disability associated with obesity, respectively. All the participants from the cohorts were randomly selected from the registries of primary health care centers and, for this study, must have a DXA scan at baseline. The software (HTSMayor) was designed according to an adapted version of the algorithm proposed by the EWGSOP and was divided into four phases: longitudinal validation of diagnostic algorithm of sarcopenia, alpha version, beta version, and release version. The software estimates appendicular skeletal muscle mass (ASM) using an anthropometric equation or DXA measurements with Chilean cut-off points. The predictive validation of the algorithm was estimated, comparing functional limitations (at least one activity of daily living, two instrumental activities of daily living, or three mobility limitations), falls, and osteoporosis at follow-ups in patients with and without sarcopenia at baseline, using adjusted logistic models. Results: After a median follow-up of 4.8 years (2078.4 person-years), 37 (9.9%) new cases of sarcopenia, out of the 374 patients without sarcopenia at baseline, were identified (incidence density rate=1.78 per 100 person-years). ASM estimated with the anthropometric equation showed both a high sensitivity and specificity as compared with those estimated by DXA measurements, yielding a concordance of 0.96. The diagnostic algorithm of sarcopenia considered in the software with the equation showed both a high sensitivity (82.1%) and specificity (94.9%) when compared with DXA (reference standard). Adults without sarcopenia (at baseline) showed better physical performance (after approximately 5 years) than adults with sarcopenia. Loss of functionality was greater in adults with sarcopenia (OR 5.0, 95% CI 2.2-11.4) than in adults without sarcopenia. In addition, the risks of falls (OR 2.2, 95% CI 1.1-4.3) and osteoporosis (OR 2.8, 95% CI 1.2-6.6) were higher in older persons with sarcopenia than those without sarcopenia. The measurements and results were completed for the beta and release tests with a mean time of 10 minutes and 11 minutes, respectively. Conclusions: We developed and validated a software for the diagnosis of sarcopenia in older Chilean adults that can be used on a mobile device or a computer with good sensitivity and specificity, thus allowing for the development of programs for the prevention, delay, or reversal of this disease. To our knowledge, HTSMayor is the first software to diagnose sarcopenia. International Registered Report Identifier (IRRID): RR2-10.2196/13657

Verified
Journal Article
Open access
PDF file
DDDominique A. Díaz
Dominique A. Díaz
LMLydia de la Caridad Lera Marques
Lydia de la Caridad Lera Marques
CMCarlos Marquez
Carlos Marquez
AVAndrea Valenzuela
Andrea Valenzuela
RSRodrigo Saguez
Rodrigo Saguez
CACecilia Albala
Cecilia Albala
Background: The leading cause of death in older people is cardiovascular diseases. Several studies have found that neck circumference (NC) is a simple anthropometric marker associated with adiposity. The aim of this study is to estimate and validate NC cut-off points as adiposity markers and analyze their association with cardiovascular and chronic metabolic diseases in older people. Methods: A cross-sectional study in 358 non-disabled, community-dwelling older people (71.7 ± 3.9 years) living in Santiago de Chile and participating in the HTSMayor study was conducted. Measurements of body composition and cardiovascular risks were evaluated. Receiver operating characteristic (ROC) curves and multiple logistic regression models were used to evaluate the association of NC with cardiovascular and chronic metabolic diseases. NC cut-off points were obtained to predict obesity, abdominal obesity, and adiposity. Results: The best performance values of neck circumference relative to obesity and adiposity were obtained with respect to abdominal obesity (40.6 cm in men and 34.2 cm in women). Higher NC values were associated with a higher area under the curve (AUC) for men and women (men: AUC = 0.84; women: AUC = 0.86). NC was significantly associated with a higher risk for diabetes mellitus (OR = 1.95), hypertension (OR = 2.42), acute myocardial infarction (OR = 4.36), and comorbidities (OR = 2.01), and a lower risk for sarcopenia (OR = 0.35). Conclusions: This study shows that NC is a useful tool for detecting abdominal obesity, obesity, and adiposity in older people and that a higher NC increases the risk of chronic diseases.

26 March 2019 in JMIR Preprints
Verified
Preprint
Open access
LMLydia de la Caridad Lera Marques
Lydia de la Caridad Lera Marques
BABárbara Angel
Bárbara Angel
CMCarlos Marquez
Carlos Marquez
RSRodrigo Saguez
Rodrigo Saguez
CACecilia Albala
Cecilia Albala
BACKGROUND The usual diagnosis of sarcopenia requires a dual-energy x-ray absorptiometry (DXA) exam, which has low accessibility in primary care for Latin American countries. OBJECTIVE The aim of this study is to design and validate software for mobile devices (Android, IOS) and computers, based on an adapted version of the diagnostic algorithm of sarcopenia proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). METHODS Follow-up exams were conducted on 430 community-dwelling Chileans 60 years and older (mean 68.2 years, SD 4.9) participating in the IsaMayor and Alexandros cohorts designed to study sarcopenia and disability associated with obesity, respectively. All the participants from the cohorts were randomly selected from the registries of primary health care centers and, for this study, must have a DXA scan at baseline. The software (HTSMayor) was designed according to an adapted version of the algorithm proposed by the EWGSOP and was divided into four phases: longitudinal validation of diagnostic algorithm of sarcopenia, alpha version, beta version, and release version. The software estimates appendicular skeletal muscle mass (ASM) using an anthropometric equation or DXA measurements with Chilean cut-off points. The predictive validation of the algorithm was estimated, comparing functional limitations (at least one activity of daily living, two instrumental activities of daily living, or three mobility limitations), falls, and osteoporosis at follow-ups in patients with and without sarcopenia at baseline, using adjusted logistic models. RESULTS After a median follow-up of 4.8 years (2078.4 person-years), 37 (9.9%) new cases of sarcopenia, out of the 374 patients without sarcopenia at baseline, were identified (incidence density rate=1.78 per 100 person-years). ASM estimated with the anthropometric equation showed both a high sensitivity and specificity as compared with those estimated by DXA measurements, yielding a concordance of 0.96. The diagnostic algorithm of sarcopenia considered in the software with the equation showed both a high sensitivity (82.1%) and specificity (94.9%) when compared with DXA (reference standard). Adults without sarcopenia (at baseline) showed better physical performance (after approximately 5 years) than adults with sarcopenia. Loss of functionality was greater in adults with sarcopenia (OR 5.0, 95% CI 2.2-11.4) than in adults without sarcopenia. In addition, the risks of falls (OR 2.2, 95% CI 1.1-4.3) and osteoporosis (OR 2.8, 95% CI 1.2-6.6) were higher in older persons with sarcopenia than those without sarcopenia. The measurements and results were completed for the beta and release tests with a mean time of 10 minutes and 11 minutes, respectively. CONCLUSIONS We developed and validated a software for the diagnosis of sarcopenia in older Chilean adults that can be used on a mobile device or a computer with good sensitivity and specificity, thus allowing for the development of programs for the prevention, delay, or reversal of this disease. To our knowledge, HTSMayor is the first software to diagnose sarcopenia. INTERNATIONAL REGISTERED REPORT RR2-10.2196/13657

13 March 2026 in JMIR Preprints
Verified
Preprint
Open access
TPTeresa Parrao
Teresa Parrao
RSRodrigo Saguez
Rodrigo Saguez
DTDaniela Thumala
Daniela Thumala
PLPatricia Lillo
Patricia Lillo
PZPedro Zitko
Pedro Zitko
ASAndrea Slachevsky
Andrea Slachevsky
BACKGROUND Cognitive complaints (CC) in individuals without dementia may predict future cognitive and functional decline. The GERO cohort aims to identify multidimensional risk factors associated with the prognosis of CC in older adults who are free of dementia. Longitudinal studies on cognitive complaints are essential for understanding their prognosis; however, such studies often face challenges in recruiting and retaining participants, which impacts the strength of the inferences drawn. Addressing these challenges is crucial for guiding future research efforts. The purpose of the study is to report the recruitment process at baseline and the attrition rates (i.e., participant dropout over time) at follow-up in the Chilean GERO cohort. OBJECTIVE To describe the baseline recruitment process and quantify attrition during follow-up in the Chilean GERO cohort, and to identify baseline factors associated with loss to follow-up among older adults with cognitive complaints who were free of dementia. METHODS The GERO cohort is a prospective study involving older adults without dementia, aged 70 years and above, living in three municipalities in Santiago, Chile. The study included assessments of cognitive performance, functionality, psychosocial factors, and other medical indicators. Baseline assessments were conducted from May 2017 to July 2021, with follow-up evaluations from December 2018 to December 2023. RESULTS Initially, 17,759 households were approached. Significant recruitment challenges included difficulties establishing contact, age limitations for participation, and high refusal rates, resulting in 291 participants being recruited at baseline. The participants were predominantly older women (80%), with an average age of 76.8 ± 5.1 years and 8.9 ± 4.8 years of education. The study attrition rate over three years was 42%. Factors associated with loss to follow-up included refusal to participate, illness, death of the participant, lack of contact after multiple attempts, and relocation. Univariate analysis revealed that age, cognitive status, and activities of daily living (ADL) were significant predictors of attrition. In contrast, in the multivariable analysis, only age and Instrumental Activities of Daily Living remained significant predictors of loss to follow-up. CONCLUSIONS Our findings highlight the need to address barriers to recruitment and retention in aging studies. They emphasize the importance of age and functional ability as predictors of attrition, underscoring the need for strategies to mitigate these challenges in future research. CLINICALTRIAL NCT04265482 in ClinicalTrials.gov.